Key Details
Annual ROE
88.64%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Nov 08, 2024Recent annual earnings:
Mar 28, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Apr 11, 2023Analyst ratings
Recent major analysts updates
18 Mar '24 Maxim Group
Hold22 Sept '23 Maxim Group
Buy26 June '23 HC Wainwright & Co.
Buy07 June '23 HC Wainwright & Co.
Buy30 Dec '22 HC Wainwright & Co.
Buy26 July '22 Maxim Group
Buy11 July '22 HC Wainwright & Co.
Buy08 Apr '22 Maxim Group
Hold03 Nov '21 HC Wainwright & Co.
Buy13 Sept '21 HC Wainwright & Co.
BuyScreeners with AGRX included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Agile Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
AGRX
GlobeNewsWire21 March 2024
PRINCETON, N.J., March 21, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2023 financial results before the market opens on Thursday, March 28, 2024.
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
AGRX
GlobeNewsWire20 March 2024
PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2023 financial results before the market opens on Friday, March 22, 2024.
Why Shares of Agile Therapeutics Jumped This Week
AGRX
The Motley Fool28 September 2023
Agile is seeing strong revenue growth. The company only has one marketed product, a birth control patch.
Agile Therapeutics, Inc. (AGRX) Q1 2023 Earnings Call Transcript
AGRX
Seeking Alpha12 May 2023
Agile Therapeutics, Inc. (NASDAQ:AGRX ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Matt Riley - Head, Investor Relations Al Altomari - Chairman & Chief Executive Officer Conference Call Participants Oren Livnat - H.C. Wainwright Operator Good day, and thank you for standing by.
FAQ
- What is the primary business of Agile Therapeutics?
- What is the ticker symbol for Agile Therapeutics?
- Does Agile Therapeutics pay dividends?
- What sector is Agile Therapeutics in?
- What industry is Agile Therapeutics in?
- What country is Agile Therapeutics based in?
- When did Agile Therapeutics go public?
- Is Agile Therapeutics in the S&P 500?
- Is Agile Therapeutics in the NASDAQ 100?
- Is Agile Therapeutics in the Dow Jones?
- When was Agile Therapeutics's last earnings report?
- When does Agile Therapeutics report earnings?
- Should I buy Agile Therapeutics stock now?
What is the primary business of Agile Therapeutics?
Agile Therapeutics is a biopharmaceutical company focused on developing innovative contraceptive solutions for women. Their main product, Twirla, is a transdermal birth control patch that offers a convenient and effective way to prevent pregnancy, aiming to improve women's health and reproductive choices.
What is the ticker symbol for Agile Therapeutics?
The ticker symbol for Agile Therapeutics is NASDAQ:AGRX
Does Agile Therapeutics pay dividends?
No, Agile Therapeutics does not pay dividends
What sector is Agile Therapeutics in?
Agile Therapeutics is in the Healthcare sector
What industry is Agile Therapeutics in?
Agile Therapeutics is in the Drug Manufacturers - Specialty & Generic industry
What country is Agile Therapeutics based in?
Agile Therapeutics is headquartered in United States
When did Agile Therapeutics go public?
Agile Therapeutics's initial public offering (IPO) was on 23 May 2014
Is Agile Therapeutics in the S&P 500?
No, Agile Therapeutics is not included in the S&P 500 index
Is Agile Therapeutics in the NASDAQ 100?
No, Agile Therapeutics is not included in the NASDAQ 100 index
Is Agile Therapeutics in the Dow Jones?
No, Agile Therapeutics is not included in the Dow Jones index
When was Agile Therapeutics's last earnings report?
Agile Therapeutics's most recent earnings report was on 8 November 2024
When does Agile Therapeutics report earnings?
The date for Agile Therapeutics's next earnings report has not been announced yet
Should I buy Agile Therapeutics stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions